MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B

Laboratory Investigation

Volumn 91, Issue 10, 2011, Pages 1472-1479

  Liffers, Sven T ^a   Munding, Johanna B ^a   Vogt, Markus ^a   Kuhlmann, Jan D ^b   Verdoodt, Berlinda ^a   Nambiar, Sandeep ^a   Maghnouj, Abdelouahid ^b   Mirmohammadsadegh, Alireza ^a   Hahn, Stephan A ^b   Tannapfel, Andrea ^a  

^a INSTITUT FÜR PATHOLOGIE   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

CDC25B; miR 148a; pancreatic ductal adenocarcinoma (PDAC)

Indexed keywords

LENTIVIRUS VECTOR; LUCIFERASE; MICRORNA; MICRORNA 148A; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL SURVIVAL; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 80053360154     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.99     Document Type: Article

References (35)

1. Carthew RW. Gene regulation by microRNAs. Curr Opin Genet Dev 2006;16:203-208. (Pubitemid 43376069)
2. Drakaki A, Iliopoulos D. MicroRNA gene networks in oncogenesis. Curr Genomics 2009;10:35-41.
3. Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol 2006;58(Suppl 1):s63-s68.
4. Szafranska AE, Doleshal M, Edmunds HS, et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem 2008;54:1716-1724.
5. Chen Y, Song Y, Wang Z, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010;14:1170-1179.
6. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008;105:13556-13561.
7. Magrelli A, Azzalin G, Salvatore M, et al. Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2009; 2:157-163.
8. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010;51:881-890.
9. Duursma AM, Kedde M, Schrier M, et al. miR-148 targets human DNMT3b protein coding region. Rna 2008;14:872-877. (Pubitemid 351574909)
10. Fujita Y, Kojima K, Ohhashi R, et al. MiR-148a attenuates paclitaxelresistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem 2010;285:19076-19084.
11. Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 2006;18:185-191. (Pubitemid 43375887)
12. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 2007;7:495-507. (Pubitemid 46985396)
13. Strausfeld U, Labbe JC, Fesquet D, et al. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 1991;351:242-245. (Pubitemid 21896574)
14. Gabrielli BG, De Souza CP, Tonks ID, et al. Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci 1996;109(part 5):1081-1093. (Pubitemid 26168260)
15. Lindqvist A, Kallstrom H, Lundgren A, et al. Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol 2005;171:35-45. (Pubitemid 41434600)
16. Bugler B, Quaranta M, Aressy B, et al. Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. Mol Cancer Ther 2006;5:1446-1451. (Pubitemid 44070480)
17. Karlsson C, Katich S, Hagting A, et al. Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol 1999;146:573-584.
18. Galaktionov K, Lee AK, Eckstein J, et al. CDC25 phosphatases as potential human oncogenes. Science 1995;269:1575-1577.
19. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:e179.
20. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26:4442-4452. (Pubitemid 47014466)
21. Hanoun N, Delpu Y, Suriawinata AA, et al. The silencing of MicroRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010;56:1107-1118.
22. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500. (Pubitemid 40617277)
23. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
24. Grimson A, Farh KK, Johnston WK, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007;27:91-105. (Pubitemid 46991392)
25. Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
26. Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol 2003;5:R1.
27. Lehmann U, Hasemeier B, Christgen M, et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008;214:17-24.
28. Kristjansdottir K, Rudolph J. Cdc25 phosphatases and cancer. Chem Biol 2004;11:1043-1051. (Pubitemid 39138756)
29. Grutzmann R, Foerder M, Alldinger I, et al. Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. Virchows Arch 2003;443:508-517. (Pubitemid 37363377)
30. Guo J, Kleeff J, Li J, et al. Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. Oncogene 2004;23:71-81. (Pubitemid 38142241)
31. Ito Y, Yoshida H, Uruno T, et al. Expression of cdc25A and cdc25B phosphatase in breast carcinoma. Breast Cancer 2004;11:295-300.
32. Ngan ES, Hashimoto Y, Ma ZQ, et al. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene 2003;22:734-739. (Pubitemid 36269286)
33. Takemasa I, Yamamoto H, Sekimoto M, et al. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res 2000;60:3043-3050. (Pubitemid 30395833)
34. Hernandez S, Bessa X, Bea S, et al. Differential expression of cdc25 cellcycle-activating phosphatases in human colorectal carcinoma. Lab Invest 2001;81:465-473. (Pubitemid 32298791)
35. Kudo Y, Yasui W, Ue T, et al. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas. Jpn J Cancer Res 1997;88:947-952. (Pubitemid 27507390)